HSBC HOLDINGS PLC - ANTARES PHARMA INC ownership

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$85,000
+16.4%
20,551
+0.5%
0.00%
Q4 2021$73,000
+40.4%
20,450
+44.6%
0.00%
Q3 2021$52,000
-11.9%
14,146
-4.7%
0.00%
Q4 2020$59,000
-19.2%
14,843
-3.9%
0.00%
Q4 2019$73,000
+35.2%
15,448
-3.9%
0.00%
Q3 2019$54,00016,0680.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders